Detalhe da pesquisa
1.
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy.
J Hepatol
; 77(4): 967-977, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714812
2.
Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects.
Br J Clin Pharmacol
; 76(6): 858-67, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23701202
3.
A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects.
Clin Pharmacol Drug Dev
; 8(6): 790-801, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30861337
4.
A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects.
Clin Pharmacol Drug Dev
; 3(6): 439-48, 2014 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27129119